FOSTER CITY, Calif.--(BUSINESS WIRE)--OXIS International (OTCBB: OXIS) (Nouveau Marche: OXIS) (FWB: OXI), a biopharmaceutical company focused on commercializing biomarker research and clinical assays, nutraceutical and therapeutic products related to oxidative stress and, through its majority interest in BioCheck, high quality immunoassay clinical kits and contract services, announced today that it has appointed Matt Spolar to its Board of Directors. Mr. Spolar currently serves as Vice President, Product Technology for Atkins Nutritionals, Inc.(“Atkins”), a market-leading portable nutrition foods company.
